Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.
Also called NCT04012775
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 201 participants
- Sponsor
- Registry
-
NCT04012775
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Russia
- Registry status
- Completed
Technical summary
Registry record NCT04012775. Randomized; no masking; primary purpose treatment. Start 2017-04-20 (actual); primary completion 2018-09-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Biological)
- Insulin Humulin® NPH
- Intervention (Biological)
- Insulin Rinsulin® NPH
- Lead sponsor
- Geropharm
Record details
- Record id
cardio:ct-nct04012775- Content hash
c072c282136eddd8b88674fe7347b847966cbbbc77bdf2fc0bafe6c4a89421aa